Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on ...

Revenue cycle company will seek to take advantage of Iodine's AI capabilities in clinical documentation integrity, ...

Baystreet.ca News Commentary – Momentum behind AI innovation is gaining traction across multiple industries, and now the U.S. government is stepping in to accelerate adoption ...

Thank you, John, and good afternoon, everyone. It is my pleasure to welcome you to Waystars' Investor conference call. Matt Hawkins, Waystar's Chief Executive Officer; and Steven Oreskovich, Waystar's ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.

Waystar Holding Corp. shows revenue growth and strategic expansion with the Iodine acquisition. Click for why high valuations and muted growth may temper WAY's appeal.

Louisville's newest public company raises nearly $1 billion © 2025 American City Business Journals. All rights reserved. Use ...

Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.

Waystar has agreed to acquire Iodine Software, an Austin-based provider of AI-powered clinical intelligence, for $1.25 billion. The sellers include majority shareholder Advent International and Iodine ...

Waystar has signed a definitive agreement to acquire AI-powered revenue cycle management company Iodine Software. The proposed $1.25 billion deal will be funded with a 50/50 mix of cash and stock ...

The acquisition will enable Waystar to automate tasks such as utilisation management and clinical documentation integrity.